Global Burn Care and Wound Care Market, by Product Type (Topical Agents {Antibiotics, Antiseptic, Antifungal, and Others {Chlorhexidine, among others}}, Wound Therapy Device {Negative Pressure Therapy Device, Hyperbaric Oxygen Equipment, Pressure Relief Devices, and Others {Electrical Stimulation Devices}}, Surgical Wound Care Products {Sutures, Staplers, and Others {Tissue Adhesives, Sealants and Glues}}, Skin Grafts {Split-thickness Grafts, Full-thickness Grafts, and Composite Grafts}, and Advanced Dressing {Foam Dressing, Collagen Dressing, Hydrogel Dressing, and Others {Hydrocolloid, Alginate, among others}}, and Traditional Burn Care {Medical Tapes, Dressings, and Cleansing Agents}), by Application (Burn Degree {First Degree, Second Degree, Third Degree, and Fourth Degree}, and Wound Type (Surgical Wounds, Ulcers {Pressure Ulcers, Diabetic Foot Ulcers, and Arterial and Venous Ulcers}, Traumatic Wounds, and Others {Microbial Infection, among others})), by End User (Hospitals and Clinics, Burn Care Centers, and Others {Home Care, among others}), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 2,801.4 million in 2022 and is expected to exhibit a CAGR of 6.0% over the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
Key players operating in market are focusing on receiving product approvals from regulatory authorities and this is expected to drive the global burn care and wound care market growth over the forecast period.
For instance, in October 2021, Solascure Limited, a U.K.-based biotechnology company focused on the development of advanced wound care products, announced that it had initiated clinical trials for Aurase Wound Gel, its investigational wound cleaning product, after receiving approval from the U.K.’s Medical and Healthcare products Regulatory Agency (MHRA).
Global Burn Care and Wound Care Market – Impact of Coronavirus (Covid-19) Pandemic
COVID-19 outbreak was first reported on December 31, 2019, in Wuhan, China. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 523 million cases and 6.3 million deaths due to Coronavirus (COVID-19) were reported up till May 22, 2022, across the globe.
The COVID-19 pandemic has adversely affected several markets across the globe and it is expected to have a similar impact on the global burn care and wound care market, owing to lockdowns in several countries across the world and disruptions in supply of raw materials required for burn care and wound care products production. Lockdowns in various countries have placed an economic burden on the private healthcare sector. Healthcare providers are facing challenges in terms of availability of manpower, equipment, consumables, and other resources to ensure safe treatment of patients with other diseases, and declining outpatient visits among others.
Browse 58 Market Data Tables and 43 Figures spread through 180 Pages and in-depth TOC on “Burn Care and Wound Care Market”- Global Forecast to 2030, by Product Type (Topical Agents {Antibiotics, Antiseptic, Antifungal, and Others {Chlorhexidine, among others}}, Wound Therapy Device {Negative Pressure Therapy Device, Hyperbaric Oxygen Equipment, Pressure Relief Devices, and Others {Electrical Stimulation Devices}}, Surgical Wound Care Products {Sutures, Staplers, and Others {Tissue Adhesives, Sealants and Glues}}, Skin Grafts {Split-thickness Grafts, Full-thickness Grafts, and Composite Grafts}, and Advanced Dressing {Foam Dressing, Collagen Dressing, Hydrogel Dressing, and Others {Hydrocolloid, Alginate, among others}}, and Traditional Burn Care {Medical Tapes, Dressings, and Cleansing Agents}), by Application (Burn Degree {First Degree, Second Degree, Third Degree, and Fourth Degree}, and Wound Type (Surgical Wounds, Ulcers {Pressure Ulcers, Diabetic Foot Ulcers, and Arterial and Venous Ulcers}, Traumatic Wounds, and Others {Microbial Infection, among others})), by End User (Hospitals and Clinics, Burn Care Centers, and Others {Home Care, among others}), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa),
To know the latest trends and insights prevalent in the global Burn Care and Wound Care market, click the link below:
https://www.coherentmarketinsights.com/market-insight/burn-care-and-wound-care-market-4836
Key players operating in market are focusing on adoption of inorganic growth strategies such as partnerships, and others in order to strengthen their position in the market. For instance, in February 2021, a collaboration was formed between Tyndall National Institute (Ireland), Royal College of Surgeons (England), DeRoyal Global Healthcare, an Ireland-based subsidiary of DeRoyal Inc. (U.S.), and Henkel Ltd., a Germany-based chemical company to develop innovative compression wound care therapy solutions.
Key Takeaways of the Global Burn Care and Wound Care Market:
- Global burn care and wound care market is expected to exhibit a CAGR of 6.0% over the forecast period, owing to rising research and development activities by market players for development of burn care and wound care products. For instance, in May 2021, RenovaCare, Inc., a U.S.-based biotechnology company initiated clinical trial to evaluate the safety of its regenerative skin stem cell solution called CellMist solution for the treatment of deep second degree burns.
- Among application, wound type segment is expected to account for the largest market share in 2022, owing to rising product launches by market players. For instance, in March, 2022, Cardinal Health, a U.S.-based health care services company launched the first surgical incise drape using industry-leading antiseptic Chlorhexidine Gluconate (CHG). The drape has feature of Avery Dennison's patented BeneHold CHG adhesive technology, which helps in reducing the risk of surgical site contamination with organisms typically associated with surgical site infections (SSIs).
- Key players operating in the global burn care and wound care market include Smith & Nephew Plc, Johnson & Johnson, ConvaTec Inc., Medtronic Plc, Medline Industries, Inc., 3M, Baxter International Inc., Cardinal Health, Mölnlycke Health Care AB, Integra LifeSciences, B. Braun Melsungen AG, DeRoyal Industries, Inc., Coloplast A/S, Advancis Medical, Essity Aktiebolag (publ), Schweitzer-Mauduit International, Inc., Medtrade Products Limited, Advanced Medical Solutions Group plc., Beiersdorf, and L&R Medical UK Ltd.
